VELARU GALACTIC EXHIBIT PACK — DIGITAL PATHOLOGY AI
Jurisdiction: United States (Federal) (us_federal)
Modality: Text / Chat
Program: Velaru Digital Pathology AI · United States (Federal) (galactic_pathology_ai_us_federal)
Product ID: pathology_ai:us_federal:bundle:text
Vertical: pathology_ai
Generated: 2026-08-11T02:36:54.955109Z
Authority: US Federal Exhibit — Digital Pathology AI External Validation Pack
Deadline: EU AI Act + sector regulator
Velaru verify: https://velaru.onrender.com/verify

EXHIBIT A — AI INVENTORY
[]

EXHIBIT B — GOVERNANCE FRAMEWORK
{
  "framework": "Velaru Mandate Registry \u2014 Digital Pathology AI",
  "exhibit_authority": "US Federal Exhibit \u2014 Digital Pathology AI External Validation Pack",
  "regulatory_frameworks": [
    "HIPAA",
    "FDA SaMD guidance",
    "EU AI Act Annex III",
    "FTC Act \u00a75",
    "EEOC Title VII",
    "NAIC Model Bulletin",
    "EO 14179 AI policy"
  ],
  "standards_alignment": [
    "POSS-2",
    "DRP-1",
    "TCB",
    "FRE 707 pre-compliance",
    "ISO 42001"
  ],
  "human_oversight": "execute Digital Pathology AI AI decision",
  "third_party_verification": "https://velaru.onrender.com/verify (operator-independent)",
  "data_lineage": "Hash-chained Ed25519 receipts; optional RFC3161 + external anchor",
  "mirror_trap": "Niche Digital Pathology AI deployer owns AI harm \u2014 vertical SaaS vendor owns liability cap. \u00b7 Federal agencies disagree on AI approach \u2014 but examiners agree internal logs are insufficient.",
  "chain_integrity": {
    "depth": 39,
    "invariant_holds": true
  }
}

EXHIBIT D — DATA INPUTS & VALIDATION
{
  "data_validation_method": "Cryptographic receipt per AI decision; public verify without trusting deployer, vendor, or Velaru operator",
  "bias_testing_proxy": "Asymmetry score from live chain signals",
  "model_change_control": "Policy lock registry \u2014 criteria hash frozen pre-dispute",
  "logging_retention": "90-day pre-dispute window minimum; permanent verify permalinks",
  "external_validator": "Nisaba LLC / Velaru",
  "validator_independence": "Client-side Ed25519 verify; BYOK tri-receipt optional",
  "headline_stat": "Digital Pathology AI \u2014 AI decision audit trail required for liability defense",
  "global_leaders_addressed": [
    "Sector regulators",
    "Vertical SaaS platforms",
    "NAIC",
    "FTC",
    "EEOC",
    "CFPB",
    "NIST"
  ]
}

MIRROR TRAP (regulatory insight)
Niche Digital Pathology AI deployer owns AI harm — vertical SaaS vendor owns liability cap. · Federal agencies disagree on AI approach — but examiners agree internal logs are insufficient.

NERVE CARDS — WHY GLOBAL LEADERS CARE
[
  {
    "title": "Niche litigation",
    "body": "Digital Pathology AI plaintiffs challenge AI decision without independent verify.",
    "source": "vertical"
  },
  {
    "title": "Insurance bind",
    "body": "Sector insurers asking AI governance questions on Digital Pathology AI accounts.",
    "source": "vertical"
  },
  {
    "title": "[United States (Federal)] Agency pincer",
    "body": "FTC, CFPB, EEOC, and DOJ all active on AI \u2014 one receipt chain satisfies cross-agency discovery.",
    "source": "jurisdiction"
  },
  {
    "title": "[United States (Federal)] Federal preemption fight",
    "body": "State laws filling void \u2014 multistate operators need jurisdiction-tagged receipts.",
    "source": "jurisdiction"
  },
  {
    "title": "[Text / Chat] Modality hook",
    "body": "Baseline \u2014 all frameworks apply to text decisions.",
    "source": "modality"
  }
]

BOOK SUMMARY: {
  "total_insureds": 0,
  "compliant": 0,
  "grace_period": 0,
  "non_compliant": 0,
  "expired": 0,
  "not_enrolled": 0,
  "compliant_pct": 0.0
}

TAM / EXPOSURE: Global Digital Pathology AI market
INSURANCE LINES: E&O, Cyber, Sector liability

DISCLAIMER: External validation evidence pack — not legal advice, not filed rate approval.